RXO Analyst Price Targets - Benzinga

RXO Inc

RXONYSE

Trade with Public

Trade with Public

$20.76

0.301.47%

마지막 업데이트: Oct 1, 10:36 AM

$20.46

N/A

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 옵션 주식 보고서

RXO Analyst Price Targets - Benzinga

RXO Analyst Price Targets

Wall Street analyst price targets and consensus rating for RXO (RXO).

Price Target Range — 11 Quarters

Analyst Consensus — 15 Analysts

1S.Buy

5Buy

7Hold

2Sell

Consensus RatingNeutral# Analysts15Avg. Consensus PT$24Upside to Avg. PT+15.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 23, 2026	Susquehanna	Harrison Bauer	Upgrade	Negative→Neutral	$20→$19
Sep 9, 2026	Wells Fargo	Christian Wetherbee	PT Raise	Equal-Weight	$22→$23
Aug 7, 2026	UBS	Thomas Wadewitz	PT Cut	Neutral	$26→$23
Aug 7, 2026	TD Cowen	Jason Seidl	PT Cut	Sell	$19→$18
Aug 7, 2026	Citigroup	Ariel Rosa	PT Cut	Neutral	$30→$23
Aug 7, 2026	Citizens	Jeff Kauffman	Upgrade	Market Perform→Market Outperform	$30
Aug 7, 2026	Truist Securities	Lucas Servera	PT Cut	Buy	$30→$28
Jul 28, 2026	TD Cowen	Jason Seidl	Downgrade	Hold→Sell	$24→$19
Jul 16, 2026	Goldman Sachs	Jordan Alliger	PT Raise	Neutral	$18→$20
Jul 15, 2026	Truist Securities	Lucas Servera	PT Raise	Buy	$26→$30
Jul 14, 2026	Susquehanna	Bascome Majors	PT Raise	Negative	$18→$20
Jul 14, 2026	BMO Capital	Fadi Chamoun	Initiate	Outperform	$35
Jul 13, 2026	Stifel	J. Bruce Chan	PT Raise	Buy	$22→$30
Jul 9, 2026	Citigroup	Ariel Rosa	PT Raise	Neutral	$24→$30
Jun 30, 2026	UBS	Thomas Wadewitz	PT Raise	Neutral	$22→$26
Jun 26, 2026	Barclays	Brandon Oglenski	PT Raise	Overweight	$20→$28
May 15, 2026	Stifel	J. Bruce Chan	Upgrade	Hold→Buy	$22
May 8, 2026	UBS	Thomas Wadewitz	PT Raise	Neutral	$17→$22
May 8, 2026	Citigroup	Ariel Rosa	PT Raise	Neutral	$17→$24
May 8, 2026	Truist Securities	Lucas Servera	PT Raise	Buy	$20→$26

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Susquehanna Upgrades RXO to Neutral, Lowers Price Target to $19

Susquehanna analyst Harrison Bauer upgrades RXO (NYSE:RXO) from Negative to Neutral and lowers the price target from $20 to $19.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on RXO, Lowers Price Target to $23

UBS analyst Thomas Wadewitz maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $26 to $23.

Benzinga Newsdesk

PRO
TD Cowen Maintains Sell on RXO, Lowers Price Target to $17.5

TD Cowen analyst Jason Seidl maintains RXO (NYSE:RXO) with a Sell and lowers the price target from $19 to $17.5.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on RXO, Lowers Price Target to $23

Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $30 to $23.

Benzinga Newsdesk

PRO
Citizens Upgrades RXO to Market Outperform, Announces $30 Price Target

Citizens analyst Jeff Kauffman upgrades RXO (NYSE:RXO) from Market Perform to Market Outperform and announces $30 price target.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on RXO, Lowers Price Target to $28

Truist Securities analyst Lucas Servera maintains RXO (NYSE:RXO) with a Buy and lowers the price target from $30 to $28.

Benzinga Newsdesk